NCT05919264 2026-04-09FOG-001 in Locally Advanced or Metastatic Solid TumorsParabilis Medicines, Inc.Phase 1/2 Recruiting595 enrolled
NCT03367741 2025-07-28Cabozantinib S-malate and Nivolumab in Treating Patients With Advanced, Recurrent, or Metastatic Endometrial CancerNational Cancer Institute (NCI)Phase 2 Active not recruiting82 enrolled
NCT03241745 2024-12-27A Study of Nivolumab in Selected Uterine Cancer PatientsMemorial Sloan Kettering Cancer CenterPhase 2 Completed35 enrolled 8 charts